Newsletter

Pipeline, markets, policy, and science. Once a week.

You’re in. Check your inbox to confirm.

More stories

In depth

The First Functional Cure for Hepatitis B Clears One Patient in Five

Bepirovirsen is the first therapy to offer people with chronic hepatitis B a shot at functional cure after a six-month course. It works in about one in five, and only in a narrow, already-treated population.

Read the story

Pipeline

See all
Neoclassical federal agency building exterior at dawn, symbolizing a regulatory safety decision
Policy

Why the FDA Put a Vision-Loss Warning on Every GLP-1 Label

The agency combed trials, real-world claims data, and case reports for two years before putting NAION on every GLP-1 label. The absolute risk is tiny, the relative signal is real, and the decision says a lot about how FDA weighs incomplete evidence.